Immunogen Inc (DELISTED) (IMGN:DL)

31.23 0.00 (0.00%) USD  |  NASDAQ  |  Feb 13, 16:00
More

Price Chart

Key Stats

View All Stats
Price and Performance
Market Cap --
52 Week High (Daily) Upgrade
52 Week Low (Daily) Upgrade
All-Time High (Daily) Upgrade
Year to Date Total Returns (Daily) Upgrade
1 Month Total Returns (Daily) Upgrade
1 Year Total Returns (Daily) --
Valuation
PE Ratio --
PE Ratio (Forward) Upgrade
PS Ratio --
Price to Book Value --
EV to EBITDA Upgrade
Dividend
Dividend --
Dividend Yield (Forward) Upgrade
Financials
Revenue (5 Year Growth) Upgrade
Revenue (Quarterly YoY Growth) Upgrade
EPS Diluted (5 Year Growth) Upgrade
EPS Diluted (Quarterly YoY Growth) Upgrade
Debt to Equity Ratio 0.1284
Return on Equity Upgrade
Return on Assets Upgrade
Risk
Beta (5Y) Upgrade
Max Drawdown (5Y) --

Ratings

Y-Rating Upgrade
Value Score Upgrade
Fundamental Score Upgrade
Valuation (Hist. Mult.) Upgrade

Profile

Immunogen Inc is a clinical-stage biotechnology company from the United States. Its focus is antibody-drug conjugate, or ADC, technology, which uses an antibody that fixes on a target (its antigen) found on tumor cells to deliver a specific cancer-killing agent.
URL https://www.immunogen.com
Investor Relations URL https://investor.immunogen.com
HQ State/Province Massachusetts
Sector  
Industry  
Equity Style Small Cap/Growth
Next Earnings Release Mar. 01, 2024 (est.)
Last Earnings Release Nov. 02, 2023
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Ratings

Y-Rating Upgrade
Value Score Upgrade
Fundamental Score Upgrade
Valuation (Hist. Mult.) Upgrade

Profile

Immunogen Inc is a clinical-stage biotechnology company from the United States. Its focus is antibody-drug conjugate, or ADC, technology, which uses an antibody that fixes on a target (its antigen) found on tumor cells to deliver a specific cancer-killing agent.
URL https://www.immunogen.com
Investor Relations URL https://investor.immunogen.com
HQ State/Province Massachusetts
Sector  
Industry  
Equity Style Small Cap/Growth
Next Earnings Release Mar. 01, 2024 (est.)
Last Earnings Release Nov. 02, 2023
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A